Mara Dierssen, MD, PhD

Phase 1 Clinical Trial of Mega Green Tea Extract in Fragile X Syndrome

An early trial of green tea extract EGCG improved cognition in Fragile X. It targets ERβ and reduces overactive PI3K/mTOR/ERK signaling linked to FXS symptoms.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (38)